Ubs Group Ag PROGENICS PHARMACEUTICALS IN Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 31, 2020
SELL
N/A
-25,005 Closed
0 $0
Q1 2020

May 01, 2020
SELL
N/A
-44,678 Reduced 64.12%
25,005 $95,000
Q4 2019

Feb 14, 2020
SELL
N/A
-95,057 Reduced 57.7%
69,683 $355,000
Q3 2019

Nov 14, 2019
BUY
N/A
82,609 Added 100.58%
164,740 $833,000
Q2 2019

Aug 14, 2019
BUY
N/A
43,011 Added 109.95%
82,131 $507,000
Q1 2019

May 14, 2019
SELL
N/A
-232,527 Reduced 85.6%
39,120 $181,000
Q4 2018

Feb 14, 2019
BUY
N/A
264,601 Added 3755.34%
271,647 $1.14 Million
Q3 2018

Nov 14, 2018
BUY
N/A
2,997 Added 74.02%
7,046 $44,000
Q2 2018

Aug 14, 2018
SELL
N/A
-113,995 Reduced 96.57%
4,049 $33,000
Q1 2018

May 15, 2018
BUY
N/A
115,197 Added 4046.26%
118,044 $880,000
Q4 2017

Feb 14, 2018
SELL
N/A
-23,200 Reduced 89.07%
2,847 $17,000
Q3 2017

Nov 14, 2017
BUY
N/A
14,229 Added 120.4%
26,047 $192,000
Q2 2017

Aug 14, 2017
SELL
N/A
-132 Reduced 1.1%
11,818 $80,000
Q1 2017

Nov 14, 2017
BUY
N/A
11,950
11,950 $113,000
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email